No abstract available
Keywords:
dopamine agonist; male; metabolic response; obesity; prolactinoma.
MeSH terms
-
Dopamine Agonists / therapeutic use
-
Humans
-
Male
-
Obesity / drug therapy
-
Obesity, Morbid* / drug therapy
-
Pituitary Neoplasms* / complications
-
Pituitary Neoplasms* / drug therapy
-
Prolactinoma* / complications
-
Prolactinoma* / drug therapy
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.